PBE vs. MSTY
PBE (Invesco Dynamic Biotechnology & Genome ETF) and MSTY (YieldMax™ MSTR Option Income Strategy ETF) are both exchange-traded funds - PBE is a Health & Biotech Equities fund tracking the Dynamic Biotech & Genome Intellidex Index (AMEX), while MSTY is a Derivative Income fund actively managed by YieldMax. PBE is passively managed, while MSTY is actively managed. Over the past year, PBE returned 34.13% vs -60.49% for MSTY. At a 0.29 correlation, their price movements are largely independent. PBE charges 0.59%/yr vs 0.99%/yr for MSTY.
Performance
PBE vs. MSTY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PBE achieves a 3.32% return, which is significantly higher than MSTY's -12.23% return.
PBE
- 1D
- 0.81%
- 1M
- 4.85%
- YTD
- 3.32%
- 6M
- 5.17%
- 1Y
- 34.13%
- 3Y*
- 10.91%
- 5Y*
- 2.31%
- 10Y*
- 8.90%
MSTY
- 1D
- 4.50%
- 1M
- -23.91%
- YTD
- -12.23%
- 6M
- -15.80%
- 1Y
- -60.49%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PBE vs. MSTY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
PBE Invesco Dynamic Biotechnology & Genome ETF | 3.32% | 24.84% | 4.67% |
MSTY YieldMax™ MSTR Option Income Strategy ETF | -12.23% | -42.71% | 212.16% |
Correlation
The correlation between PBE and MSTY is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.29 |
Correlation (All Time) Calculated using the full available price history since Feb 22, 2024 | 0.29 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PBE vs. MSTY — Risk / Return Rank
PBE
MSTY
PBE vs. MSTY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and YieldMax™ MSTR Option Income Strategy ETF (MSTY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PBE | MSTY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.79 | ||
| Sortino ratioReturn per unit of downside risk | +4.32 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 0.82 | +0.49 |
| Calmar ratioReturn relative to maximum drawdown | 2.92 | -0.84 | +3.77 |
| Martin ratioReturn relative to average drawdown | 8.21 | -1.25 | +9.46 |
Loading charts...
Drawdowns
PBE vs. MSTY - Drawdown Comparison
The maximum PBE drawdown since its inception was -45.69%, smaller than the maximum MSTY drawdown of -71.79%. Use the drawdown chart below to compare losses from any high point for PBE and MSTY.
Loading charts...
Drawdown Indicators
| PBE | MSTY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.69% | -71.79% | +26.10% |
Max Drawdown (1Y)Largest decline over 1 year | -11.73% | -71.79% | +60.06% |
Max Drawdown (3Y)Largest decline over 3 years | -22.43% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -34.71% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -37.84% | — | — |
Current DrawdownCurrent decline from peak | -1.00% | -65.49% | +64.49% |
Average DrawdownAverage peak-to-trough decline | -16.21% | -26.61% | +10.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.17% | 48.38% | -44.21% |
Volatility
PBE vs. MSTY - Volatility Comparison
The current volatility for Invesco Dynamic Biotechnology & Genome ETF (PBE) is 6.04%, while YieldMax™ MSTR Option Income Strategy ETF (MSTY) has a volatility of 19.30%. This indicates that PBE experiences smaller price fluctuations and is considered to be less risky than MSTY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PBE | MSTY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.04% | 19.30% | -13.26% |
Volatility (6M)Calculated over the trailing 6-month period | 13.67% | 49.85% | -36.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.01% | 61.63% | -42.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.48% | 71.87% | -49.39% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.91% | 71.87% | -46.96% |
PBE vs. MSTY - Expense Ratio Comparison
PBE has a 0.59% expense ratio, which is lower than MSTY's 0.99% expense ratio.
Dividends
PBE vs. MSTY - Dividend Comparison
PBE's dividend yield for the trailing twelve months is around 1.02%, less than MSTY's 230.78% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MSTY YieldMax™ MSTR Option Income Strategy ETF | 230.78% | 294.61% | 104.56% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PBE Invesco Dynamic Biotechnology & Genome ETF | 1.02% | 1.00% | 0.05% | 0.02% | 0.00% | 0.00% | 0.04% | 0.00% | 0.00% | 0.57% | 0.38% | 1.12% |
Frequently Asked Questions
PBE and MSTY have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MSTY has higher volatility (19.30%) compared to PBE (6.04%). In terms of maximum drawdown, PBE dropped -45.69% vs MSTY's -71.79%.
On 1-year performance, PBE leads with 34.13% vs -60.49% for MSTY. On fees, PBE is cheaper at 0.59% per year. On volatility, PBE has been the lower-risk option at 6.04%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, PBE has performed better with a 34.13% return vs -60.49%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PBE is cheaper with a 0.59% expense ratio, compared with 0.99% for MSTY.
MSTY has the higher dividend yield at 230.78%, compared with 1.02% for PBE.
PBE is categorized as Health & Biotech Equities, while MSTY is Derivative Income. They also come from different issuers: Invesco and YieldMax. Their fees differ too: 0.59% for PBE and 0.99% for MSTY.
PBE currently has the higher Sharpe Ratio (1.81 vs -0.99), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PBE and MSTY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer